Cases 41 - 50 of 342
Lindis Biotech, GmbH v. Amgen Inc.
as 1:2022cv00035
Plaintiff:
Lindis Biotech, GmbH
Defendant:
Amgen Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
United States of America, ex r v. Amgen Inc.
as 22-18
Plaintiff:
United States of America, Ex Rel. Joseph Piacentile and Kevin B. Kilcoyne, State of California, State of Delaware and others
Petitioner / Appellant:
Joseph Piacentile and Kevin Kilcoyne
Defendant / Appellee:
U.S. Oncology, Inc.
Defendant:
Amgen, Inc., Amerisource Bergen Corp., Amerisource Bergen Specialty Group, Inc. and others
Amgen Inc. v. Sandoz Inc.
as 22-1150
Cross Appellant:
AMGEN INC.
Defendant / Appellant:
SANDOZ INC.
Defendant / Appellee:
MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED and others
Amgen Inc. v. Sandoz Inc.
as 22-1151
Plaintiff / Appellant:
AMGEN INC.
Defendant / Appellee:
SANDOZ INC., MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD. and others
Amgen Inc. v. Sandoz Inc.
as 22-1147
Cross Appellant:
AMGEN INC.
Defendant / Appellee:
MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD., GLENMARK PHARMACEUTICALS LIMITED and others
Defendant / Appellant:
ZYDUS PHARMACEUTICALS (USA) INC. and SANDOZ INC.
Amgen Inc. v. Sandoz Inc.
as 22-1149
Plaintiff / Appellant:
AMGEN INC.
Defendant / Appellee:
SANDOZ INC., MANKIND PHARMA LTD., TORRENT PHARMACEUTICALS LTD. and others
Kevin Wilcox v. Dearborn Insurance Company et al
as 2:2021cv04605
Defendant:
Dearborn Insurance Company and Amgen Inc Life Insurance Plan
Plaintiff:
Kevin Wilcox
Cause Of Action: 29 U.S.C. § 1132
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2021cv00712
Defendant:
MSN Pharmaceuticals Inc., MSN Life Sciences Private Limited and MSN Laboratories Private Limited
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. et al v. Aurobindo Pharma Limited et al
as 1:2021cv00662
Defendant:
Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
In Re In the Matter of the Ex Parte Application of Betapharm Arzneimittel GmbH
as 2:2021mc00894
In Re:
In the Matter of
Petitioner:
betapharm Arzneimittel GmbH
Respondent:
Amgen Inc.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
